Medical Care
Global Preclinical CRO Market Research Report 2025
- Mar 27, 25
- ID: 15943
- Pages: 81
- Figures: 86
- Views: 44
The global market for Preclinical CRO was valued at US$ 17780 million in the year 2024 and is projected to reach a revised size of US$ 30580 million by 2031, growing at a CAGR of 8.2% during the forecast period.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
The Global key players of Preclinical CRO include Wuxi AppTec, Charles River, Labcorp, etc. The top three players hold a share about 43%. US & Canada is the largest market, and has a share about 45%. In terms of product type, Bioanalysis and DMPK Studies is the largest segment, which occupied for a share of about 47%. For application, Pharmaceutical Companies is the largest segment, which has a share about 79%.
This report aims to provide a comprehensive presentation of the global market for Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical CRO.
The Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
The Global key players of Preclinical CRO include Wuxi AppTec, Charles River, Labcorp, etc. The top three players hold a share about 43%. US & Canada is the largest market, and has a share about 45%. In terms of product type, Bioanalysis and DMPK Studies is the largest segment, which occupied for a share of about 47%. For application, Pharmaceutical Companies is the largest segment, which has a share about 79%.
This report aims to provide a comprehensive presentation of the global market for Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical CRO.
The Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical CRO Market Perspective (2020-2031)
2.2 Global Preclinical CRO Growth Trends by Region
2.2.1 Global Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Preclinical CRO Market Dynamics
2.3.1 Preclinical CRO Industry Trends
2.3.2 Preclinical CRO Market Drivers
2.3.3 Preclinical CRO Market Challenges
2.3.4 Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical CRO Players by Revenue
3.1.1 Global Top Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preclinical CRO Revenue
3.4 Global Preclinical CRO Market Concentration Ratio
3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2024
3.5 Global Key Players of Preclinical CRO Head office and Area Served
3.6 Global Key Players of Preclinical CRO, Product and Application
3.7 Global Key Players of Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Breakdown Data by Type
4.1 Global Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Preclinical CRO Breakdown Data by Application
5.1 Global Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Preclinical CRO Market Size (2020-2031)
6.2 North America Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical CRO Market Size (2020-2031)
7.2 Europe Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical CRO Market Size (2020-2031)
9.2 Latin America Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wuxi AppTec
11.1.1 Wuxi AppTec Company Details
11.1.2 Wuxi AppTec Business Overview
11.1.3 Wuxi AppTec Preclinical CRO Introduction
11.1.4 Wuxi AppTec Revenue in Preclinical CRO Business (2020-2025)
11.1.5 Wuxi AppTec Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Preclinical CRO Introduction
11.2.4 Charles River Revenue in Preclinical CRO Business (2020-2025)
11.2.5 Charles River Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Preclinical CRO Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Details
11.5.2 PPD, Inc. Business Overview
11.5.3 PPD, Inc. Preclinical CRO Introduction
11.5.4 PPD, Inc. Revenue in Preclinical CRO Business (2020-2025)
11.5.5 PPD, Inc. Recent Development
11.6 ICON Plc.
11.6.1 ICON Plc. Company Details
11.6.2 ICON Plc. Business Overview
11.6.3 ICON Plc. Preclinical CRO Introduction
11.6.4 ICON Plc. Revenue in Preclinical CRO Business (2020-2025)
11.6.5 ICON Plc. Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Preclinical CRO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Preclinical CRO Business (2020-2025)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Preclinical CRO Business (2020-2025)
11.9.5 ChemPartner Recent Development
11.10 JOINN Lab
11.10.1 JOINN Lab Company Details
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Preclinical CRO Business (2020-2025)
11.10.5 JOINN Lab Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Details
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Preclinical CRO Business (2020-2025)
11.11.5 EVOTEC Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Preclinical CRO Business (2020-2025)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Preclinical CRO Business (2020-2025)
11.13.5 Crown Bioscience Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Details
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Preclinical CRO Business (2020-2025)
11.14.5 Champion Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical CRO Market Perspective (2020-2031)
2.2 Global Preclinical CRO Growth Trends by Region
2.2.1 Global Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Preclinical CRO Market Dynamics
2.3.1 Preclinical CRO Industry Trends
2.3.2 Preclinical CRO Market Drivers
2.3.3 Preclinical CRO Market Challenges
2.3.4 Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical CRO Players by Revenue
3.1.1 Global Top Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preclinical CRO Revenue
3.4 Global Preclinical CRO Market Concentration Ratio
3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2024
3.5 Global Key Players of Preclinical CRO Head office and Area Served
3.6 Global Key Players of Preclinical CRO, Product and Application
3.7 Global Key Players of Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Breakdown Data by Type
4.1 Global Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Preclinical CRO Breakdown Data by Application
5.1 Global Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Preclinical CRO Market Size (2020-2031)
6.2 North America Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical CRO Market Size (2020-2031)
7.2 Europe Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical CRO Market Size (2020-2031)
9.2 Latin America Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wuxi AppTec
11.1.1 Wuxi AppTec Company Details
11.1.2 Wuxi AppTec Business Overview
11.1.3 Wuxi AppTec Preclinical CRO Introduction
11.1.4 Wuxi AppTec Revenue in Preclinical CRO Business (2020-2025)
11.1.5 Wuxi AppTec Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Preclinical CRO Introduction
11.2.4 Charles River Revenue in Preclinical CRO Business (2020-2025)
11.2.5 Charles River Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Preclinical CRO Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Details
11.5.2 PPD, Inc. Business Overview
11.5.3 PPD, Inc. Preclinical CRO Introduction
11.5.4 PPD, Inc. Revenue in Preclinical CRO Business (2020-2025)
11.5.5 PPD, Inc. Recent Development
11.6 ICON Plc.
11.6.1 ICON Plc. Company Details
11.6.2 ICON Plc. Business Overview
11.6.3 ICON Plc. Preclinical CRO Introduction
11.6.4 ICON Plc. Revenue in Preclinical CRO Business (2020-2025)
11.6.5 ICON Plc. Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Preclinical CRO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Preclinical CRO Business (2020-2025)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Preclinical CRO Business (2020-2025)
11.9.5 ChemPartner Recent Development
11.10 JOINN Lab
11.10.1 JOINN Lab Company Details
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Preclinical CRO Business (2020-2025)
11.10.5 JOINN Lab Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Details
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Preclinical CRO Business (2020-2025)
11.11.5 EVOTEC Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Preclinical CRO Business (2020-2025)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Preclinical CRO Business (2020-2025)
11.13.5 Crown Bioscience Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Details
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Preclinical CRO Business (2020-2025)
11.14.5 Champion Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Safety Pharmacology
Table 5. Key Players of Others
Table 6. Global Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Preclinical CRO Market Share by Region (2020-2025)
Table 10. Global Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Preclinical CRO Market Share by Region (2026-2031)
Table 12. Preclinical CRO Market Trends
Table 13. Preclinical CRO Market Drivers
Table 14. Preclinical CRO Market Challenges
Table 15. Preclinical CRO Market Restraints
Table 16. Global Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Preclinical CRO Market Share by Players (2020-2025)
Table 18. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2024)
Table 19. Ranking of Global Top Preclinical CRO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Preclinical CRO, Headquarters and Area Served
Table 22. Global Key Players of Preclinical CRO, Product and Application
Table 23. Global Key Players of Preclinical CRO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Preclinical CRO Revenue Market Share by Type (2020-2025)
Table 27. Global Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Preclinical CRO Revenue Market Share by Type (2026-2031)
Table 29. Global Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Preclinical CRO Revenue Market Share by Application (2020-2025)
Table 31. Global Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Preclinical CRO Revenue Market Share by Application (2026-2031)
Table 33. North America Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Wuxi AppTec Company Details
Table 49. Wuxi AppTec Business Overview
Table 50. Wuxi AppTec Preclinical CRO Product
Table 51. Wuxi AppTec Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 52. Wuxi AppTec Recent Development
Table 53. Charles River Company Details
Table 54. Charles River Business Overview
Table 55. Charles River Preclinical CRO Product
Table 56. Charles River Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 57. Charles River Recent Development
Table 58. Labcorp Company Details
Table 59. Labcorp Business Overview
Table 60. Labcorp Preclinical CRO Product
Table 61. Labcorp Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 62. Labcorp Recent Development
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Preclinical CRO Product
Table 66. Eurofins Scientific Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. PPD, Inc. Company Details
Table 69. PPD, Inc. Business Overview
Table 70. PPD, Inc. Preclinical CRO Product
Table 71. PPD, Inc. Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 72. PPD, Inc. Recent Development
Table 73. ICON Plc. Company Details
Table 74. ICON Plc. Business Overview
Table 75. ICON Plc. Preclinical CRO Product
Table 76. ICON Plc. Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 77. ICON Plc. Recent Development
Table 78. Pharmaron Company Details
Table 79. Pharmaron Business Overview
Table 80. Pharmaron Preclinical CRO Product
Table 81. Pharmaron Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 82. Pharmaron Recent Development
Table 83. Inotiv Company Details
Table 84. Inotiv Business Overview
Table 85. Inotiv Preclinical CRO Product
Table 86. Inotiv Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 87. Inotiv Recent Development
Table 88. ChemPartner Company Details
Table 89. ChemPartner Business Overview
Table 90. ChemPartner Preclinical CRO Product
Table 91. ChemPartner Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 92. ChemPartner Recent Development
Table 93. JOINN Lab Company Details
Table 94. JOINN Lab Business Overview
Table 95. JOINN Lab Preclinical CRO Product
Table 96. JOINN Lab Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 97. JOINN Lab Recent Development
Table 98. EVOTEC Company Details
Table 99. EVOTEC Business Overview
Table 100. EVOTEC Preclinical CRO Product
Table 101. EVOTEC Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 102. EVOTEC Recent Development
Table 103. Medicilon Company Details
Table 104. Medicilon Business Overview
Table 105. Medicilon Preclinical CRO Product
Table 106. Medicilon Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 107. Medicilon Recent Development
Table 108. Crown Bioscience Company Details
Table 109. Crown Bioscience Business Overview
Table 110. Crown Bioscience Preclinical CRO Product
Table 111. Crown Bioscience Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 112. Crown Bioscience Recent Development
Table 113. Champion Oncology Company Details
Table 114. Champion Oncology Business Overview
Table 115. Champion Oncology Preclinical CRO Product
Table 116. Champion Oncology Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 117. Champion Oncology Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Preclinical CRO Picture
Figure 2. Global Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Preclinical CRO Market Share by Type: 2024 VS 2031
Figure 4. Bioanalysis and DMPK Studies Features
Figure 5. Toxicology Testing Features
Figure 6. Safety Pharmacology Features
Figure 7. Others Features
Figure 8. Global Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Preclinical CRO Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. Other Case Studies
Figure 13. Preclinical CRO Report Years Considered
Figure 14. Global Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Preclinical CRO Market Share by Region: 2024 VS 2031
Figure 17. Global Preclinical CRO Market Share by Players in 2024
Figure 18. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Preclinical CRO Revenue in 2024
Figure 20. North America Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Preclinical CRO Market Share by Country (2020-2031)
Figure 22. United States Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Preclinical CRO Market Share by Country (2020-2031)
Figure 26. Germany Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Preclinical CRO Market Share by Region (2020-2031)
Figure 34. China Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Preclinical CRO Market Share by Country (2020-2031)
Figure 42. Mexico Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Preclinical CRO Market Share by Country (2020-2031)
Figure 46. Turkey Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Wuxi AppTec Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 50. Charles River Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 51. Labcorp Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 53. PPD, Inc. Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 54. ICON Plc. Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 55. Pharmaron Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 56. Inotiv Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 57. ChemPartner Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 58. JOINN Lab Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 59. EVOTEC Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 60. Medicilon Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 61. Crown Bioscience Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 62. Champion Oncology Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Safety Pharmacology
Table 5. Key Players of Others
Table 6. Global Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Preclinical CRO Market Share by Region (2020-2025)
Table 10. Global Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Preclinical CRO Market Share by Region (2026-2031)
Table 12. Preclinical CRO Market Trends
Table 13. Preclinical CRO Market Drivers
Table 14. Preclinical CRO Market Challenges
Table 15. Preclinical CRO Market Restraints
Table 16. Global Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Preclinical CRO Market Share by Players (2020-2025)
Table 18. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2024)
Table 19. Ranking of Global Top Preclinical CRO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Preclinical CRO, Headquarters and Area Served
Table 22. Global Key Players of Preclinical CRO, Product and Application
Table 23. Global Key Players of Preclinical CRO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Preclinical CRO Revenue Market Share by Type (2020-2025)
Table 27. Global Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Preclinical CRO Revenue Market Share by Type (2026-2031)
Table 29. Global Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Preclinical CRO Revenue Market Share by Application (2020-2025)
Table 31. Global Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Preclinical CRO Revenue Market Share by Application (2026-2031)
Table 33. North America Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Wuxi AppTec Company Details
Table 49. Wuxi AppTec Business Overview
Table 50. Wuxi AppTec Preclinical CRO Product
Table 51. Wuxi AppTec Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 52. Wuxi AppTec Recent Development
Table 53. Charles River Company Details
Table 54. Charles River Business Overview
Table 55. Charles River Preclinical CRO Product
Table 56. Charles River Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 57. Charles River Recent Development
Table 58. Labcorp Company Details
Table 59. Labcorp Business Overview
Table 60. Labcorp Preclinical CRO Product
Table 61. Labcorp Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 62. Labcorp Recent Development
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Preclinical CRO Product
Table 66. Eurofins Scientific Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. PPD, Inc. Company Details
Table 69. PPD, Inc. Business Overview
Table 70. PPD, Inc. Preclinical CRO Product
Table 71. PPD, Inc. Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 72. PPD, Inc. Recent Development
Table 73. ICON Plc. Company Details
Table 74. ICON Plc. Business Overview
Table 75. ICON Plc. Preclinical CRO Product
Table 76. ICON Plc. Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 77. ICON Plc. Recent Development
Table 78. Pharmaron Company Details
Table 79. Pharmaron Business Overview
Table 80. Pharmaron Preclinical CRO Product
Table 81. Pharmaron Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 82. Pharmaron Recent Development
Table 83. Inotiv Company Details
Table 84. Inotiv Business Overview
Table 85. Inotiv Preclinical CRO Product
Table 86. Inotiv Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 87. Inotiv Recent Development
Table 88. ChemPartner Company Details
Table 89. ChemPartner Business Overview
Table 90. ChemPartner Preclinical CRO Product
Table 91. ChemPartner Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 92. ChemPartner Recent Development
Table 93. JOINN Lab Company Details
Table 94. JOINN Lab Business Overview
Table 95. JOINN Lab Preclinical CRO Product
Table 96. JOINN Lab Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 97. JOINN Lab Recent Development
Table 98. EVOTEC Company Details
Table 99. EVOTEC Business Overview
Table 100. EVOTEC Preclinical CRO Product
Table 101. EVOTEC Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 102. EVOTEC Recent Development
Table 103. Medicilon Company Details
Table 104. Medicilon Business Overview
Table 105. Medicilon Preclinical CRO Product
Table 106. Medicilon Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 107. Medicilon Recent Development
Table 108. Crown Bioscience Company Details
Table 109. Crown Bioscience Business Overview
Table 110. Crown Bioscience Preclinical CRO Product
Table 111. Crown Bioscience Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 112. Crown Bioscience Recent Development
Table 113. Champion Oncology Company Details
Table 114. Champion Oncology Business Overview
Table 115. Champion Oncology Preclinical CRO Product
Table 116. Champion Oncology Revenue in Preclinical CRO Business (2020-2025) & (US$ Million)
Table 117. Champion Oncology Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Preclinical CRO Picture
Figure 2. Global Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Preclinical CRO Market Share by Type: 2024 VS 2031
Figure 4. Bioanalysis and DMPK Studies Features
Figure 5. Toxicology Testing Features
Figure 6. Safety Pharmacology Features
Figure 7. Others Features
Figure 8. Global Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Preclinical CRO Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. Other Case Studies
Figure 13. Preclinical CRO Report Years Considered
Figure 14. Global Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Preclinical CRO Market Share by Region: 2024 VS 2031
Figure 17. Global Preclinical CRO Market Share by Players in 2024
Figure 18. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Preclinical CRO Revenue in 2024
Figure 20. North America Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Preclinical CRO Market Share by Country (2020-2031)
Figure 22. United States Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Preclinical CRO Market Share by Country (2020-2031)
Figure 26. Germany Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Preclinical CRO Market Share by Region (2020-2031)
Figure 34. China Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Preclinical CRO Market Share by Country (2020-2031)
Figure 42. Mexico Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Preclinical CRO Market Share by Country (2020-2031)
Figure 46. Turkey Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Wuxi AppTec Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 50. Charles River Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 51. Labcorp Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 53. PPD, Inc. Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 54. ICON Plc. Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 55. Pharmaron Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 56. Inotiv Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 57. ChemPartner Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 58. JOINN Lab Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 59. EVOTEC Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 60. Medicilon Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 61. Crown Bioscience Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 62. Champion Oncology Revenue Growth Rate in Preclinical CRO Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232